University of Michigan
Provisional title: Stem Cell Therapy in ALS: Where We Are Today.

Dr. Eva L. Feldman received her M.D. and Ph.D. degrees from the University of Michigan (U-M), completed a neurology residency at the Johns Hopkins Hospital and returned to U-M for a Neuromuscular fellowship. In addition to her clinical practice and position as the Russell N. DeJong Professor of Neurology at the U-M Medical School, Dr. Feldman is Director of the A. Alfred Taubman Medical Research Institute and Director of Research for the U-M ALS Clinic. She also runs her own 30-scientist laboratory, the Program for Neurology Research & Discovery, and is the principal investigator of two first-ever FDA approved human clinical trials of intraspinal stem cell implantation therapy for ALS.

Dr. Feldman has published more than 350 original peer-reviewed articles, 60 book chapters, and 4 books and is the Principle Investigator (PI) or co-PI of 8 NIH grants and multiple foundation grants. She is Past President of the Peripheral Nerve Society and was President of the American Neurological Association from 2011-2013. Among Dr. Feldman’s greatest accomplishments is her training of scientists and neurologists. Nine scientists received their Ph.D. degrees under her supervision. She has trained 40 postdoctoral fellows in her laboratory to become neuroscientists, and 50 neurologists have trained under her to specialize in the understanding and treatment of neuromuscular and neurodegenerative diseases, with an emphasis on ALS and neuropathy. Among her numerous awards, she has received both the Early and Distinguished Career Development Awards from U-M. She was elected into both the Johns Hopkins Society of Scholars, the Association of American Physicians and the National Academy of Medicine, and was named 2016 National Clinician of the Year by Castle Connolly Best Doctors in America.